Vivos Therapeutics (VVOS) Institutional Ownership

$2.46
-0.11 (-4.28%)
(As of 04/25/2024 ET)

Institutional Ownership Changes (13F Filings) for Vivos Therapeutics (NASDAQ:VVOS)

Current
Institutional Ownership
Percentage
26.35%
Number of
Institutional Buyers
(last 12 months)
1
Total
Institutional Inflows
(last 12 months)
$709.08K
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$38.45M
Get VVOS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Vivos Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

VVOS Institutional Buying and Selling by Quarter

Vivos Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/13/2024Armistice Capital LLC57,000$709K0.0%N/A4.286%
1/16/2024Strategic Wealth Investment Group LLC128,789$1.60M0.2%-96.0%9.683%
4/24/2023Strategic Wealth Investment Group LLC3,219,705$1.10M0.2%N/A12.874%
4/20/2023Strategic Wealth Investment Group LLC232,737$1.10M0.2%N/A0.931%
4/18/2023 Godsey & Gibb Inc.92,999$32K0.0%N/A0.372%
2/10/2023Bard Associates Inc.201,704$81K0.0%-6.9%0.806%
11/16/2022 SeaCrest Wealth Management LLC40,000$26K0.0%N/A0.174%
11/9/2022Boston Partners78,454$51K0.0%-36.8%0.341%
11/4/2022Russell Investments Group Ltd.365,901$236K0.0%-11.1%1.590%
10/24/2022Perkins Capital Management Inc.56,500$37K0.0%-65.5%0.246%
7/29/2022Perkins Capital Management Inc.163,800$211K0.2%+9.2%0.712%
7/29/2022Russell Investments Group Ltd.411,589$530K0.0%-3.1%1.789%
5/10/2022Boston Partners137,354$368K0.0%+27.2%0.597%
5/5/2022Russell Investments Group Ltd.424,801$1.14M0.0%+39.2%1.846%
5/2/2022National Asset Management Inc.98,574$265K0.0%+24.4%0.428%
4/20/2022Perkins Capital Management Inc.150,050$402K0.3%+10.3%0.652%
4/12/2022 Griffin Asset Management Inc.70,200$188K0.0%+63.3%0.305%
2/10/2022Perkins Capital Management Inc.136,050$306K0.2%-7.1%0.591%
2/4/2022Boston Partners108,015$243K0.0%+131.5%0.469%
2/3/2022 Cambridge Investment Research Advisors Inc.19,200$43K0.0%+60.0%0.083%
1/28/2022 Griffin Asset Management Inc.43,000$97K0.0%-13.1%0.187%
1/28/2022National Asset Management Inc.79,270$179K0.0%+55.5%0.344%
1/21/2022Russell Investments Group Ltd.305,096$684K0.0%+554.0%1.326%
11/16/2021Schonfeld Strategic Advisors LLC34,443$139K0.0%N/A0.151%
11/16/2021National Asset Management Inc.50,987$206K0.0%+46.9%0.224%
11/16/2021Two Sigma Investments LP157,324$636K0.0%N/A0.690%
11/12/2021WMS Partners LLC12,167$49K0.0%-27.0%0.053%
11/12/2021Blueshift Asset Management LLC18,826$76K0.0%N/A0.083%
11/9/2021BlackRock Inc.48,905$198K0.0%+255.8%0.214%
11/8/2021Avalon Investment & Advisory329,322$1.33M0.0%+73.6%1.444%
11/8/2021Russell Investments Group Ltd.46,651$188K0.0%N/A0.205%
11/5/2021Boston Partners46,651$188K0.0%N/A0.205%
11/2/2021 Cambridge Investment Research Advisors Inc.12,000$48K0.0%-68.0%0.053%
10/25/2021Perkins Capital Management Inc.146,500$592K0.4%-9.8%0.642%
8/17/2021Walleye Capital LLC150,000$743K0.0%N/A0.658%
8/16/2021WMS Partners LLC16,667$153K0.0%N/A0.073%
8/16/2021Archon Capital Management LLC215,000$1.06M0.1%N/A0.942%
8/13/2021Renaissance Technologies LLC19,200$95K0.0%N/A0.084%
8/13/2021Northern Trust Corp11,483$57K0.0%N/A0.050%
8/13/2021Geode Capital Management LLC47,661$235K0.0%+285.0%0.209%
The Gold Grab of the Century (Ad)

When central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.

That's why we have released our Free Precious Metals Investment Guide.
8/13/2021Vanguard Group Inc.383,891$1.90M0.0%N/A1.683%
8/12/2021Bard Associates Inc.215,500$1.07M0.3%N/A0.945%
8/11/2021Millrace Asset Group Inc.93,993$465K0.2%N/A0.412%
8/10/2021National Asset Management Inc.34,718$172K0.0%+21.9%0.152%
8/10/2021 Cambridge Investment Research Advisors Inc.37,551$186K0.0%N/A0.165%
7/30/2021Avalon Investment & Advisory189,739$939K0.0%+12.0%0.832%
5/21/2021Citadel Advisors LLC15,846$105K0.0%N/A0.069%
5/18/2021Millennium Management LLC78,898$524K0.0%-5.4%0.346%
5/18/2021Citadel Advisors LLC15,846$105K0.0%N/A0.069%
5/14/2021Alpha Paradigm Partners LLC9,921$66K0.0%N/A0.054%
5/14/2021K.J. Harrison & Partners Inc45,419$302K0.0%-50.3%0.249%
5/13/2021Avalon Investment & Advisory169,414$1.13M0.0%N/A0.930%
5/12/2021Geode Capital Management LLC12,380$82K0.0%N/A0.068%
5/10/2021Royce & Associates LP348,000$2.31M0.0%+16.0%1.911%
5/7/2021BlackRock Inc.11,541$77K0.0%N/A0.063%
5/4/2021 Griffin Asset Management Inc.59,700$396K0.1%N/A0.328%
2/17/2021Jane Street Group LLC32,237$191K0.0%N/A0.182%
2/16/2021Walleye Capital LLC74,500$440K0.0%N/A0.422%
2/9/2021Perkins Capital Management Inc.20,000$118K0.1%N/A0.113%
2/8/2021Royce & Associates LP300,000$1.77M0.0%N/A1.698%
2/8/2021K.J. Harrison & Partners Inc91,322$540K0.1%N/A0.517%
(Data available from 1/1/2016 forward)

VVOS Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of VVOS shares?

During the previous two years, 9 institutional investors and hedge funds held shares of Vivos Therapeutics. The most heavily invested institutionals were Strategic Wealth Investment Group LLC ($1.60M), Armistice Capital LLC ($709K), National Asset Management Inc. ($265K), Russell Investments Group Ltd. ($236K), Bard Associates Inc. ($81K), Boston Partners ($51K), and Perkins Capital Management Inc. ($37K).Learn more on VVOS's institutional investors.

What percentage of Vivos Therapeutics stock is owned by institutional investors?

26.35% of Vivos Therapeutics stock is owned by institutional investors. Learn more on VVOS's institutional investor holdings.

Which institutional investors have been buying Vivos Therapeutics stock?

The following institutional investors have purchased Vivos Therapeutics stock in the last 24 months: Strategic Wealth Investment Group LLC ($3.45M), Russell Investments Group Ltd. ($119.71K), Godsey & Gibb Inc. ($93.00K), Armistice Capital LLC ($57K), SeaCrest Wealth Management LLC ($40K), Boston Partners ($29.34K), and National Asset Management Inc. ($19.30K).

How much institutional buying is happening at Vivos Therapeutics?

Institutional investors have bought a total of 3,824,539 shares in the last 24 months. This purchase volume represents approximately $43.32M in transactions.

Which Vivos Therapeutics major shareholders have been selling company stock?

The following institutional investors have sold Vivos Therapeutics stock in the last 24 months: Strategic Wealth Investment Group LLC ($3.09M), Perkins Capital Management Inc. ($107.30K), Russell Investments Group Ltd. ($58.90K), Boston Partners ($45.69K), and Bard Associates Inc. ($15K).

How much institutional selling is happening at Vivos Therapeutics?

Institutional investors have sold a total of 3,317,804 shares in the last 24 months. This volume of shares sold represents approximately $42.26M in transactions.


This page (NASDAQ:VVOS) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners